Smith+Nephew Adds Total Hip Arthroplasty to Cori Surgical Robot
Smith+Nephew (NYSE:SNN) today announced that it has expanded the indications for its Cori Surgical System to include total hip replacement surgery.
The London-based company previously designed the wearable robotic system for total knee replacement surgery. The new indication with RI.Hip Navigation could help maximize accuracy and reproducibility by providing patient-specific component alignment to the ATH, the company says.
“The addition of RI.Hip Navigation to the Cori system further strengthens Smith+Nephew’s Real Intelligence digital ecosystem and underscores our commitment to advancing clinical outcomes in total hip replacement surgery,” Randy Kilburn, Vice-Principal executive chairman and general manager of reconstruction, robotics and digital surgery, said in a Press release. “We look forward to bringing the opportunity to further improve patient outcomes and satisfaction to a wider community of surgeons through the rapid adoption of our Cori Surgical System.”
Smith+Nephew’s RI.Hip Navigation recently received FDA 510(k) clearance for use in the Cori system. The company said software installations will begin immediately for a limited number of hospitals and outpatient surgery centers in the United States with broad commercial availability later this year. In addition, the new indication will be introduced in the European and Asia-Pacific markets once regulatory approvals are finalized.